The Mesothelioma Center News
Latest T-Cell Clinical Trial Opens for Mesothelioma Patients
- by Tim Povtak
- Research & Clinical Trials
- Oct 8, 2020
Memorial Sloan Kettering Cancer Center in New York City has begun recruiting patients with pleural mesothelioma for its latest — and potentially most promising — clinical trial involving T-cell…
Read More
Congress Fails to Vote on Asbestos Ban Legislation
- by Tim Povtak
- Asbestos Exposure & Bans
- Oct 7, 2020
The U.S. House of Representatives last week failed to advance once-promising legislation that effectively would have banned asbestos, frustrating advocates once again. H.R. 1603, titled the Alan Reinstein Ban…
Read More
Johnson & Johnson Will Pay $100M in Baby Powder Lawsuits
- by Tim Povtak
- Legislation & Litigation
- Oct 6, 2020
Pharmaceutical giant Johnson & Johnson has agreed to pay more than $100 million to settle more than a thousand lawsuits claiming its iconic talc-based baby powder caused cancer, according to…
Read More
FDA Approves Opdivo, Yervoy Combination for Mesothelioma
- by Tim Povtak
- Treatment & Doctors
- Oct 5, 2020
The U.S. Food and Drug Administration has approved the immunotherapy combination of Opdivo and Yervoy for first-line treatment of unresectable malignant pleural mesothelioma. It was the first new drug…
Read More
KCIC Report: Mesothelioma Lawsuits on the Rise in US
- by Tim Povtak
- Legislation & Litigation
- Sep 29, 2020
While the incidence of malignant mesothelioma in the United States continued its gradual decline, the tendency to sue for damages drastically increased in recent years, according to a KCIC study.
Read More
Gene Therapy Clinical Trial for Mesothelioma Moving Forward
- by Tim Povtak
- Research & Clinical Trials
- Sep 23, 2020
A much-anticipated, phase III clinical trial studying the use of gene therapy to combat pleural mesothelioma cancer has made a promising start. Interest is growing in what many believe…
Read More
Mesothelioma Trial to Test Cancer Vaccine with Immunotherapy
- by Tim Povtak
- Research & Clinical Trials
- Sep 14, 2020
A research team at Oslo University Hospital in Norway has opened a mesothelioma clinical trial using the novel UV1 cancer vaccine alongside a promising immunotherapy combination. UV1 is a…
Read More
Peer Review Finds EPA’s Asbestos Risk Evaluation Flawed
- by Tim Povtak
- Asbestos Exposure & Bans
- Sep 2, 2020
The Science Advisory Committee on Chemicals found considerable failings and an underestimation of danger to the general public in a draft risk evaluation of asbestos submitted earlier this year…
Read More
Georgia-Pacific Pledges $1B to Bestwall Asbestos Trust Fund
- by Tim Povtak
- Asbestos Exposure & Bans
- Aug 25, 2020
Georgia-Pacific has pledged $1 billion to fund an asbestos trust for bankrupt affiliate Bestwall LLC, clearing the path to a settlement of longstanding liability claims involving mesothelioma cancer. Bloomberg…
Read More
New Lung Cancer Trial Could Benefit Mesothelioma Patients
- by Sean Marchese
- Research & Clinical Trials
- Aug 19, 2020
Pharmaceutical giant Merck has teamed up with Novocure to test its cornerstone immunotherapy, pembrolizumab (Keytruda), alongside Tumor Treating Fields. The new phase II clinical research trial is focusing on…
Read More
